Archives of Clinical Infectious Diseases

Published by: Kowsar

Epidemiology and Treatment Outcome of Mucormycosis in Khuzestan, Southwest of Iran

Roohangiz Nashibi 1 , 2 , Sara Afzalzadeh 1 , 2 , Mohammad Javad Mohammadi 3 , 4 , 5 , Ahmad Reza Yari 6 and Farid Yousefi 1 , 2 , *
Authors Information
1 Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Infectious and Tropical Diseases, Razi Hospital, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Abadan School of Medical Sciences, Abadan, Iran
4 Razi Teaching Hospital, Clinical Research Development Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 Student Research Committee, Department of Environmental Health Engineering, School of Public Health and Environmental Technologies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6 Research Center for Environmental Pollutants, Qom University of Medical Sciences, Qom, Iran
Article information
  • Archives of Clinical Infectious Diseases: January 2017, 12 (1); e37221
  • Published Online: October 9, 2016
  • Article Type: Research Article
  • Received: February 18, 2016
  • Revised: September 3, 2016
  • Accepted: September 28, 2016
  • DOI: 10.5812/archcid.37221

To Cite: Nashibi R, Afzalzadeh S, Mohammadi M J, Yari A R, Yousefi F. Epidemiology and Treatment Outcome of Mucormycosis in Khuzestan, Southwest of Iran, Arch Clin Infect Dis. 2017 ; 12(1):e37221. doi: 10.5812/archcid.37221.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Kontoyiannis DP, Lewis RE. Agents of mucormycosis and entomophthoramycosis. 2010;
  • 2. Chowdhary A, Agarwal K, Meis JF. Filamentous Fungi in Respiratory Infections. What Lies Beyond Aspergillosis and Mucormycosis? PLoS Pathog. 2016; 12(4): 1005491[DOI][PubMed]
  • 3. Sharma D, Dahal K, Pathak B, Dahal U. Case of early-disseminated Rhizopus microsporus var. microsporus mucormycosis in a renal transplant patient. Int Med Case Rep J. 2016; 9: 139-43[DOI][PubMed]
  • 4. Vaezi A, Moazeni M, Rahimi M, Hoog S, Badali H. Mucormycosis in Iran: a systematic review. Mycoses. 2016;
  • 5. Chakrabarti A, Singh R. Mucormycosis in India: unique features. Mycoses. 2014; 57 Suppl 3: 85-90[DOI][PubMed]
  • 6. Epstein JB, Kupferman SB, Zabner R, Rejali A, Hopp ML, Lill M, et al. Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review. Supportive Care Cancer. 2016; : 1-4
  • 7. Faraji E, Nakhjavani M, Mashrabi O, Maleki S, Maleki R. A brief review of mucormycosis: Report of five cases. BJMMR. 2016; 11(9): 1-5
  • 8. Yari AR, Goudarzi G, Geravandi S, Dobaradaran S, Yousefi F, Idani E, et al. Study of ground-level ozone and its health risk assessment in residents in Ahvaz city, Iran during 2013. Toxin Reviews. 2016; 35(3-4): 201-6
  • 9. Park JH, Park SH, Kang EG, Kyung G, An HD, An S. Cutaneous mucormycosis in a patient with diabetes mellitus. Ewha Med J. 2016; 39(1): 10-3
  • 10. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 54 Suppl 1-34[DOI][PubMed]
  • 11. Miceli MH, Kauffman CA. Treatment options for mucormycosis. Cur Treat Options Infect Dis. 2015; 7(3): 142-54
  • 12. Mendez HH, Hidalgo A. Endodontic patient with rhinocerebral mucormycosis. Revista Odontologica Mexicana. 2015; 19(2): 120-5
  • 13. Lim MY, Alker AP, Califano S, Trembath DG, Alby K, Gilligan PH, et al. Concurrent Disseminated Nocardiosis and GI Mucormycosis in a Stem-Cell Transplantation Recipient. J Clin Oncol. 2016; 34(10): 84-6[DOI][PubMed]
  • 14. Hong HL, Lee YM, Kim T, Lee JY, Chung YS, Kim MN, et al. Risk factors for mortality in patients with invasive mucormycosis. Infect Chemother. 2013; 45(3): 292-8[DOI][PubMed]
  • 15. Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012; 367(23): 2214-25[DOI][PubMed]
  • 16. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41(5): 634-53[DOI][PubMed]
  • 17. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012; 54 Suppl 1-22[DOI][PubMed]
  • 18. Goudarzi G, Geravandi S, Foruozandeh H, Babaei AA, Alavi N, Niri MV, et al. Cardiovascular and respiratory mortality attributed to ground-level ozone in Ahvaz, Iran. Environ Monit Assess. 2015; 187(8): 487[DOI][PubMed]
  • 19. Salmanzadeh S, Yousefi F, Ahmadi F, Geravandi S, Moien M, Mohammadi M, et al. Evaluation of Nosocomial Infections in a Teaching Hospital. Avicenna J Clin Microbiol Infect. 2015; 2(3)
  • 20. Mohinisingh D. Mucormycosis an Emerging Fungal Infection. Indian J app Res. 2015; 5(8): 661-4
  • 21. Sachdeva K. Rhino-oculo Cerebral Mucormycosis with Multiple Cranial Nerve Palsy in Diabetic Patient: Review of Six Cases. Indian J Otolaryngol Head Neck Surg. 2013; 65(4): 375-9[DOI][PubMed]
  • 22. Saegeman V, Maertens J, Ectors N, Meersseman W, Lagrou K. Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital. Med Mycol. 2010; 48(2): 245-54[DOI][PubMed]
  • 23. Khor B, Lee M, Leu H, Liu J. Rhinocerebral mucormycosis in Taiwan. J microbiol immunol infect. 2003; 36(4): 266-9
  • 24. Barati M, Talebi-Taher M, Nojomi M, Kerami F. Ten-year experience of rhinocerebral zygomycosis in a teaching hospital in Tehran. Arch Clin Infect Dis. 2010; 5(3): 117-20
  • 25. Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009; 15(9): 1395-401[DOI][PubMed]
  • 26. Sarvestani AS, Pishdad G, Bolandparvaz S. Predisposing factors for mucormycosis in patients with diabetes mellitus; an experience of 21 years in southern iran. Bulletin Emerg Traum. 2013; 1(4): 164
  • 27. Komur S, İnal A, Kurtaran B, Ulu A, Uguz A, Aksu H, et al. Mucormycosis: a 10-year experience at a tertiary care center in Turkey. Turkish J Med Sci. 2016; 46(1): 58-62
  • 28. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). Br J Haematol. 1997; 99(2): 331-6[PubMed]
  • 29. Bartzokas CA. Relationship between the metereological conditions and the air-borne fungal flora of the Athens metropolitan area. Mycopathologia. 1975; 57(1): 35-8[PubMed]
  • 30. El-Herte RI, Baban TA, Kanj SS. Mucormycosis: a review on environmental fungal spores and seasonal variation of human disease. Adv Infect Dis. 2012; 2(3): 76
  • 31. Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006; 44(4): 335-42[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments